These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 210393)

  • 41. Isolation of glycoproteins of parainfluenza I (Sendai) by Helix pomatia Lectin column.
    Bartzatt R; Martin M
    Biosci Rep; 1986 Jun; 6(6):591-5. PubMed ID: 3021254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent infection of a cell line of mouse origin after cell fusion by u.v.-inactivated Sendai virus.
    Schnitzer TJ; Watkins JF
    J Gen Virol; 1980 Jan; 46(1):219-26. PubMed ID: 6243344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibody to rat brain actin antigenically enhanced with HVJ (Sendai virus) M protein.
    Hiruma S; Hashimoto S
    Histochemistry; 1988; 90(1):1-8. PubMed ID: 2852660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial assembly of envelope particles of HVJ (Sendai virus). Fusion activity of envelope particles.
    Hosaka Y; Semba T; Fukai K
    J Gen Virol; 1974 Dec; 25(3):391-404. PubMed ID: 4374505
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemiluminescence: an early event in the interaction of Sendai and influenza viruses with mouse spleen cells. I. The role of the envelope glycoproteins in the stimulation of chemiluminescence.
    Peterhans E
    Virology; 1980 Sep; 105(2):445-55. PubMed ID: 6252685
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunoelectrophoretic study on the host antigens of Sendai virus cultivated in different substrates (embryonated hen eggs and KB cells). Note II. Analysis of KB cell host antigens.
    Samuel I; Ghyka G; Portocală R
    Virologie; 1978; 29(3):219-24. PubMed ID: 211708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells.
    Kamihira O; Nakashima I; Hasegawa T; Ando K; Isobe K; Nagase F; Hasegawa Y; Yoshida T; Kawashima K; Yoshida T
    Immunol Lett; 1985; 11(2):75-81. PubMed ID: 3002972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.
    Orvell C; Grandien M
    J Immunol; 1982 Dec; 129(6):2779-87. PubMed ID: 6183344
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.
    Gething MJ; White JM; Waterfield MD
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2737-40. PubMed ID: 208074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the HN, F, NP and M proteins of Sendai virus by recombinant vaccinia viruses and their contribution to protective immunity against Sendai virus infections in mice.
    Sakaguchi T; Takao S; Kiyotani K; Fujii Y; Nakayama T; Yoshida T
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():479-84. PubMed ID: 8383180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
    Schrader JW; Edelman GM
    J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interferon production in human T lymphoblastoid cells].
    Imanishi J; Hoshino S; Matsuoka H; Kita M; Minowada J; Kishida T
    C R Seances Soc Biol Fil; 1982; 176(2):230-4. PubMed ID: 6178482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homologous interference induced by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
    Kimura Y; Norrby E; Nagata I; Ito Y; Shimokata K
    J Gen Virol; 1976 Nov; 33(2):333-43. PubMed ID: 186564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologic properties of purified Sendai virus glycoproteins.
    Orvell C; Norrby E
    J Immunol; 1977 Dec; 119(6):1882-7. PubMed ID: 72108
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro curing of persistent infection of HVJ (sendai virus) carrier tumor cells by spleen cells.
    Ogura H; Sato H; Hatano M
    Gan; 1981 Aug; 72(4):504-11. PubMed ID: 6171472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.
    Dave VP; Allan JE; Slobod KS; Smith FS; Ryan KW; Takimoto T; Power UF; Portner A; Hurwitz JL
    Virology; 1994 Mar; 199(2):376-83. PubMed ID: 7510085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transformation of intramembrane particles of HVJ (Sendai virus) envelopes from an invisible to visible form on aging of virions.
    Kim J; Hama K; Miyake Y; Okada Y
    Virology; 1979 Jun; 95(2):523-35. PubMed ID: 223291
    [No Abstract]   [Full Text] [Related]  

  • 59. Disulfide bonds in Sendai virus glycoproteins.
    Hardwick JM; Bussell RH
    Intervirology; 1979; 11(5):300-6. PubMed ID: 222708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphological changes in Ehrlich ascites tumor cells during the cell fusion reaction with HVJ (Sendai virus). III. Morphological characterization of HVJ glycoproteins integrated into the plasma membrane and their internalization by coated vesicles.
    Kim J; Okada Y
    Exp Cell Res; 1982 Jul; 140(1):127-36. PubMed ID: 6286330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.